Testing Veverimer for metabolic acidosis in kidney disease
Part of Hormones & metabolism clinical trials.
This study tests an oral medicine called Veverimer to see if it safely corrects low bicarbonate levels (metabolic acidosis) in people with chronic kidney disease. It might help you feel better and protect your kidneys.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You have chronic kidney disease with a low bicarbonate level (between 12 and 20 in your blood).
- You are not expected to need dialysis or a kidney transplant during the study.
- You do not have serious stomach or bowel problems, and you have not had bariatric surgery.
- You are not taking certain acid-reducing medications or specific other drugs (like GLP-1 agonists) unless stable for a period.
- You are willing to keep your diet similar throughout the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether taking sodium bicarbonate changes “energy” in cells and improves metabolic acidosis (an acid build-up) in people with moderate-to-severe chronic kidney disease. You may be able to join if your kidney function and blood bicarbonate levels fit their targets and you meet safety rules.
This trial tests whether adding an “alkali” treatment (to raise low blood bicarbonate) can improve blood vessel and kidney graft function in people whose kidney transplant is about 1 year old. It may help if you have lower-than-normal bicarbonate levels while on stable transplant and blood pressure medicines.
This trial tests whether taking sodium bicarbonate tablets by mouth can help correct low bicarbonate levels in people on hemodialysis, compared to using higher bicarbonate in the dialysis fluid. It aims to find a safer and more effective way to treat metabolic acidosis, a common condition in dialysis patients.
This study tests a type of dialysis that uses different levels of bicarbonate to see if it can improve health for people with kidney failure. It may help patients who are already on regular dialysis.
This trial tests if giving sodium bicarbonate helps critically ill patients who have both metabolic acidosis (too much acid in the blood) and acute kidney injury (sudden kidney trouble). It aims to see if this treatment can improve outcomes.
This study tests whether a medication called veverimer can help reduce bone loss in adults with osteopenia (early bone thinning) by lowering the acid load from their diet. Participants must be 50 or older, eat a typical Western diet, and have low bone density but not full osteoporosis.
Hear when a new CKD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.